278 related articles for article (PubMed ID: 19077818)
21. Biventricular pacing and defibrillator use in chronic heart failure.
Cesario DA; Turner JW; Dec GW
Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
[TBL] [Abstract][Full Text] [Related]
22. [Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment].
Serdoz LV; Fabris E; Lutman C; Merlo M; Zecchin M; Sinagra G
G Ital Cardiol (Rome); 2012 Sep; 13(9):592-601. PubMed ID: 22825344
[TBL] [Abstract][Full Text] [Related]
23. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
Al-Khatib SM; Sanders GD; Mark DB; Lee KL; Bardy GH; Bigger JT; Buxton AE; Connolly S; Kadish A; Moss A; Feldman AM; Ellenbogen KA; Singh S; Califf RM;
Am Heart J; 2005 Jun; 149(6):1020-34. PubMed ID: 15976783
[TBL] [Abstract][Full Text] [Related]
24. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
25. Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?
Ray IB; Reddy VY
Int J Cardiol; 2005 Jan; 98(1):15-20. PubMed ID: 15676160
[TBL] [Abstract][Full Text] [Related]
26. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
[TBL] [Abstract][Full Text] [Related]
28. Implantable cardioverter-defibrillators confer survival benefit in patients with chronic obstructive pulmonary disease.
Razak E; Kamireddy S; Saba S
Pacing Clin Electrophysiol; 2010 Sep; 33(9):1125-30. PubMed ID: 20487355
[TBL] [Abstract][Full Text] [Related]
29. Implanted cardioverter defibrillators for the prevention of sudden death.
Dorian P; Talajic M; Tang A
Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK
Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832
[TBL] [Abstract][Full Text] [Related]
31. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
Weintraub WS
Circulation; 2001 Sep; 104(13):1457-8. PubMed ID: 11571235
[No Abstract] [Full Text] [Related]
32. Electrocardiographic predictors of sudden cardiac death.
Carey MG
J Cardiovasc Nurs; 2008; 23(2):175-82. PubMed ID: 18382261
[TBL] [Abstract][Full Text] [Related]
33. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
Goldberger JJ; Passman R
J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
[TBL] [Abstract][Full Text] [Related]
34. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
35. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
[TBL] [Abstract][Full Text] [Related]
36. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study.
Stecker EC; Vickers C; Waltz J; Socoteanu C; John BT; Mariani R; McAnulty JH; Gunson K; Jui J; Chugh SS
J Am Coll Cardiol; 2006 Mar; 47(6):1161-6. PubMed ID: 16545646
[TBL] [Abstract][Full Text] [Related]
37. Do patients at high risk of nonsudden cardiac death benefit from prophylactic ICD therapy?
Scott PA; Sterns LD; Tang AS
Curr Opin Cardiol; 2012 Jan; 27(1):1-7. PubMed ID: 22123603
[TBL] [Abstract][Full Text] [Related]
38. [How many leads are needed for an ICD?].
Schaumann A; Gödde M; Tönnis T
Herz; 2005 Nov; 30(7):591-5. PubMed ID: 16333583
[TBL] [Abstract][Full Text] [Related]
39. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.
Kadish AH; Reiffel JA; Naccarelli GV; DiMarco JP
Am J Cardiol; 2008 Sep; 102(5A):29G-37G. PubMed ID: 18722189
[TBL] [Abstract][Full Text] [Related]
40. Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function.
Al-Dadah AS; Voeller RK; Rahgozar P; Lawton JS; Moon MR; Pasque MK; Damiano RJ; Moazami N
J Cardiothorac Surg; 2007 Jan; 2():6. PubMed ID: 17222353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
